Sign In
Buy ECOR
$6.09
-0.205 (-3.26%)
At Close: Jul 31, 2026
Ecora Resources takes royalty over Phalaborwa rare earths project
03:43am, Monday, 01'st Jul 2024
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) has agreed to acquire a 0.85% Gross Revenue Royalty (GRR) over the Phalaborwa rare earth project in South Africa for a total cash consideration of
Ecora Resources shares "cheap", says broker after copper update
06:41am, Wednesday, 26'th Jun 2024
Shares in Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) are "cheap", said broker Peel Hunt in a short note following an update on a project over which Ecora has a royalty agreement. Peel pick
electroCore Announces the Commercial Launch of TAC-STIM™
08:00am, Tuesday, 25'th Jun 2024
ROCKAWAY, N.J., June 25, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, is thrilled to announce the Commercial Off the Shelf
ROCKAWAY, N.J., June 03, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a commercial-stage bioelectronic medicine and wellness company, today annou
Wall Street Analysts See a 251.77% Upside in electroCore (ECOR): Can the Stock Really Move This High?
10:55am, Thursday, 30'th May 2024
The average of price targets set by Wall Street analysts indicates a potential upside of 251.8% in electroCore (ECOR). While the effectiveness of this highly sought-after metric is questionable, the p
Ecora Resources PLC Announces Transaction in Own Shares
01:15pm, Monday, 20'th May 2024
LONDON, UNITED KINGDOM / ACCESSWIRE / May 20, 2024 / Ecora Resources PLC (LSE:ECOR)(TSX:ECOR) announces that on 20 May 2024, it purchased 200,000 ordinary shares of 2p each in the Company (the "Shares
Wall Street Analysts Think electroCore (ECOR) Could Surge 215.86%: Read This Before Placing a Bet
10:56am, Tuesday, 14'th May 2024
The average of price targets set by Wall Street analysts indicates a potential upside of 215.9% in electroCore (ECOR). While the effectiveness of this highly sought-after metric is questionable, the p
electroCore, Inc. (ECOR) Q1 2024 Earnings Call Transcript
10:19pm, Wednesday, 08'th May 2024
electroCore, Inc. (NASDAQ:ECOR ) Q1 2024 Earnings Conference Call May 8, 2024 4:30 PM ET Company Participants Dan Goldberger - CEO Brian Posner - CFO Conference Call Participants Jeffrey Cohen - Laden
ElectroCore, Inc. (ECOR) Reports Q1 Loss, Tops Revenue Estimates
06:46pm, Wednesday, 08'th May 2024
ElectroCore, Inc. (ECOR) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.50. This compares to loss of $1.24 per share a year ago.
electroCore Announces First Quarter 2024 Financial Results
04:05pm, Wednesday, 08'th May 2024
Record first quarter 2024 net sales of $5.4 million, an increase of 96% over first quarter 2023 Company to host a conference call and webcast today, May 8, 2024 at 4:30 PM EST
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
04:05pm, Friday, 03'rd May 2024
ROCKAWAY, N.J., May 03, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that on May 1, 2
electroCore to Announce First Quarter March 31, 2024 Financial Results on Wednesday, May 8, 2024
08:04am, Wednesday, 01'st May 2024
ROCKAWAY, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial result
Truvaga™ Plus Demonstrates Health Benefits in Latest Consumer Study, Paving the Way for Market Expansion
08:00am, Tuesday, 30'th Apr 2024
ROCKAWAY, N.J., April 30, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the results of
electroCore Announces the Launch of Truvaga Plus® for General Wellness
08:30am, Monday, 08'th Apr 2024
ROCKAWAY, N.J., April 08, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the launch of its direct-to-consume
electroCore Expands Intellectual Property Portfolio
08:00am, Tuesday, 02'nd Apr 2024
ROCKAWAY, N.J., April 02, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has received patent issue n
